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SUMMARY 
The objective of the study was to investigate the recent trends and magnitude of 
pediatric HIV-infection in the Niger Delta of Nigeria. It is a descriptive study of 1,559 
consecutively recruited children (0-16 years), in whom laboratory requests for HIV 
screening were made, and seen in the Pediatrics Department of the University of Port 
Harcourt Teaching Hospital between January 1999 to December 2004 were evaluated 
for HIV – infection. The overall prevalence obtained was 25.8%. HIV-1 constituted the 
predominant viral serotype (97.6%) compared to HIV-2 (2.4%). The peak HIV 
seropositivity occurred in pediatrics 6-8 years. There was no statistically significant 
difference in prevalence rate based on gender (OR = 1, p = 0.98). Children with clinical 
diagnosis of bronchopneumonia, neonatal sepsis, septicemia and pulmonary tuberculosis 
had higher prevalence of HIV seropositivity. There is a trend of increasing HIV 
prevalence from 1999 to 2004 (χ 2 for trend= 6.23, p = 0.39). History of previous blood 
transfusion was not significantly associated with HIV positivity (OR = 0.94, p = 0.94). 
This study shows that, in spite of the anti HIV campaign, there is a high prevalence of 
HIV among children attending tertiary health institution in the Niger Delta of Nigeria 
and the trend is increasing over the last 5 years. This calls for a re-intensified effort on 
health education and risk control programme, provision of antiretroviral regimen to 
prevent mother-to-child transmission of HIV, provision of supportive environment for 
voluntary counseling and confidential testing of pregnant women coupled with the 
provision of pediatric antiretroviral therapy to reduce HIV-related mortality and 
morbidity of HIV-infected Nigerian children. 
 
[ Afr J Health Sci. 2006;13: 80-85] 
*Published online before print 
 
Introduction 
There is no doubt that HIV/AIDS remains the 
greatest health problem worldwide.  An 
estimated 40 million people are now living 
with HIV/AIDS, 95% of them in developing 
countries [1].  Conservative estimate indicate 
that 3 million children are currently living with 
HIV and about 3.8 million have already died 
of HIV before their 15th birthday [2]. 
         In Nigeria, the prevalence of HIV has 
increased steadily from 1.8% in 1991 to 5.0% 
in 2003 [3].  The vast majority of children 
born to HIV-infected mother acquire the virus 
in utero, at the time of labor and delivery or 
postnatally through breastfeeding [4-6].   
 
 
Although prevention of mother-to-child 
transmission of HIV has been successful in the 
United States and Europe, due to the use of 
abbreviated antiretroviral regimens, all of 
these advances have had little impact in sub-
Saharan Africa where paradoxically > 90% of 
the 3 million HIV-infected children currently 
live [7]. With less than 5% of pregnant women 
in resource-poor countries in sub-Saharan 
Africa having access to prenatal testing and 
preventive treatment, the burden of pediatric 
HIV infection is likely to increase in future 
[8].  Although a lot of work has been done in 
various part of the world on the extent and 
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paucity of data on pediatric HIV infection 
particularly in Nigeria. This study is therefore 
an attempt to investigate the recent trend in, 
and magnitude of, pediatric HIV-infection 
among children presenting to the Pediatric 
Department of the University of Port Harcourt 
Teaching Hospital and for which the clinician 
requested HIV screening.  
 
Materials and Methods 
The study was conducted at the University of 
Port Harcourt Teaching Hospital. This is a 500 
bed tertiary hospital offering prenatal and 
pediatric care to residents in the cosmopolitan 
oil rich city of Port Harcourt .The city is in the 
heart of the oil and gas industry of the Niger 
Delta of Nigeria with a large population of 
migrant and expatriate workers from all parts 
of the world.    
         The subjects for this study consisted of 
1599 consecutively recruited children aged 0-
16 years out of a total of 27,0165 attending the 
Hospital within the study period of 1st January 
1999 to 31st December 2004. To be included in 
the study, the child was aged <16 years, there 
should be a request for HIV screening by the 
pediatrician (following clinical suspicion) and 
the parents were willing to give informed 
consent.  Written informed consent was 
obtained from the parents after counseling. An 
anonymous questionnaire regarding age, sex, 
history of blood transfusion was collected 
from the children’s parents. The clinical 
diagnosis by the clinician at the time of 
presentation was also noted. The subjects were 
recruited from both the outpatient and 
inpatient departments of the Hospital.  
 
Sample processing and laboratory assay  
Whole blood was collected by venepuncture 
(2ml) into EDTA anticoagulated tubes and 
(2ml) into plain tubes without anticoagulant.  
All samples were screened using a double 
ELlSA method as provided in the 
commercially available second generation 
Genscreen (Bio Rad, France) and 
Immunocomb (Orgenics, Israel) enzyme 
linked immunosorbent assay for the qualitative 
and differential diagnosis of HIV. Initially 
reactive samples to the double ELISA test 
were confirmed using the p24 antigen based 
test (Bio Rad, France). Children who exhibited 
a positive result to both tests were assumed to 
have been infected based on International 




All statistical analysis was carried out using 
the software SPSS (Version 9 Inc. Chicago, 
IL). Statistical analysis included descriptive 
statistics of mean and bivariate analysis of chi-
square test. A p-value of < 0.05 was 




A total of 1599 children between 0 – 16 years 
comprising of 787 females and 812 males, 
mean age 1.72 + 3.02 years constituted the 
subjects for this study.  Few parents (60) who 
initially declined their children being tested 
eventually gave informed consent after some 
sessions of pre-test counseling. The overall 
prevalence of HIV was 25.8%.  HIV-1 was the 
predominant viral serotype (97.6%) compared 
to 2.4% for HIV-2.  The age-specific HIV 
seroprevalence rate is shown in figure 1. The 
peak HIV-seropositivity occurred in children 
6-8 years (31%). There was no statistically 
significant difference between seroprevalence 
in males and females with 203 of 787 males 
(25.7%) and 209 of 812 females (25.8%) being 
seropositive for HIV (OR = 1, p = 0.98). The 
children with clinical diagnosis of 
bronchopneumonia, neonatal sepsis, 
septicemia and pulmonary tuberculosis, oral 
thrush and meningitis were found to have 
higher prevalence of HIV seropositivity as 
shown in table 1. There was no statistically 
significant difference in the trended change in 
HIV prevalence over the 5 years under review 
(χ2 for trend = 6.23; p = 0.39) as shown in 
figure 2. A previous history of blood 
transfusion was not associated with HIV 
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 Table 1: Prevalence of HIV in pediatrics based on Clinical Symptoms 
Symptoms Number Screened Number Positive % Positive 
Low Birth Weight 13 2 15.7 
Neonatal Jaundice 62 6 9.7 
Neonatal sepsis 29 15 51.7 
Routine Screening 29 - - 
Pulmonary 
tuberculosis 
105 47 44.8 
Weight Loss 117 31 26.5 
Abandoned Babies 70 19 27.1 
Anemia 42 2 4.8 
Diarrhea 87 18 20.7 
Lymphadenopathy 39 7 17.9 
Malaria 210 7 3.3 
Meningitis 23 8 34.8 
Neuropathy 17 3 17.6 
Oral thrush 11 4 36.4 
Persistent Fever 313 96 30.7 
Pneumonia 95 53 55.8 
Rape 13 1 7.7 
Septicemia 139 65 46.7 
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The overall seroprevalence rate observed in 
this study among pediatrics was 25.8%.  This 
value is much higher than the national sentinel 
seroprevalence rate of 5.0% in 2003 [3] and 
prevalence’s of 5.0% and 11% obtained in 
previous studies [10,11] among 1100 
consecutively recruited children in Kinshasa 
and among 368 children 2 – 14 years of age at 
Manayemo hospital Zaire. The higher 
prevalence obtained in this present study 
compared to that observed in the National 
sentinel seroprevalence report may be due to 
the fact that our study was carried out in a 
tertiary hospital and involved children for 
which there was already a high index of 
suspicion of HIV infection and brings to bare 
the fact that pediatric HIV infection among 
pediatrics residing in the Niger Delta of 
Nigeria is in explosion. Blood transfusion was 
not found to be significantly associated with 
HIV seropositivity. The observation of lack of 
significant association between history of 
previous blood transfusion and HIV positivity 
is discordant with previous report [10], which 
found history of previous blood transfusion a 
significant risk factor for HIV seropositivity 
among Zairian children.  Although blood 
transfusion services in Nigeria is still at a sub-
optimal level and the national blood 
transfusion service is yet to be set up, the 
regular supply of highly sensitive and specific  
 
 
HIV screening kits by the health ministry may 
be responsible for the reduced risk of  
transfusion-transmissible HIV infection in 
Nigeria. Since history of previous blood 
transfusion was not found to be significantly 
associated with HIV positivity among 
Nigerian children in this study, it becomes 
apparent that majority of HIV-infected 
children in Nigeria may have become infected 
through vertical transmission. While the 
reported rate of transmission of HIV from 
mother-to- child is as low as 1% in Europe and 
North America, it is as high as 40% in some 
African and Asian studies [12,13]. More than 
90% of HIV infections in children result from 
mother-to-child transmission [14]. With the 
advent of routine antiretroviral regimen for the 
prevention of mother-to-child transmission of 
HIV in many developed countries, lower rates 
are now being described [15]. 
      In this study we observed an increase in 
HIV prevalence from 23.4% in 1999 to 25.3% 
in 2004. This observation is consistent with 
report from the 2003 HIV seroprevalence 
sentinel report which showed that the 
prevalence of HIV in the adult population in 
Nigeria has increased from 1.8% in 1991, to 
3.8% in 1993, 4.5% in 1996, 5.4% in 1999, 
5.8% in 2001 and declined non-significantly to 
5.0% in 2003(3). The main determinant of 
childhood infection is the scale and magnitude 
of HIV infection among the adult population. 
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maintained, the burden of pediatric HIV 
infection and mortality in the Niger Delta in 
particular and Nigeria in general is likely to 
increase.   
       Preventive measures including the 
provision of antiretroviral regimen for the 
prevention of mother to child transmission, 
provision of supportive environment for 
voluntary counseling and confidential testing 
of pregnant women are advocated. There is 
also the need for International agencies to 
remain committed to the goals specified in the 
June 2001 declaration of the United Nation 
General Assembly special session on 
HIV/AIDS to reduce the proportion of infants 
infected with HIV by 20% by 2005 and 50% 
by 2010. In order to reach these goals, a 
comprehensive strategy to prevent HIV 
infection in infants and young children should 
be developed and promoted in an integrated 
approach to health care delivery particularly in 
sub-Saharan Africa. These strategies should 
ideally consist of elements such as primary 
prevention of HIV infection in women and 
their partners, prevention of HIV transmission 
among HIV infected women, prevention of 
HIV transmission from women to their infants 
and young children, the provision of care, 
treatment and support for HIV infected 
women, their children and families. 
        In this study when symptomatology did 
exist in children seropositive for HIV, 
bronchopneumonia, neonatal sepsis, 
septicemia and pulmonary tuberculosis, oral 
thrush and meningitis were the commonest 
presentations. These clinical features 
associated with HIV seropositivity are similar 
to those listed in the CDC revised 
classification system for human 
immunodeficiency virus infection in children 
[16].  We found HIV-1 the predominant viral 
serotype responsible for pediatric HIV 
infection in the Niger Delta of Nigeria. This 
observation is cordant with previous reports 
[17,18] that found HIV-1 the predominant 
viral strain in Nigeria. 
 
Conclusion 
This study found a trend of increasing 
prevalence of HIV seropositivity in children in 
our study area between 1999 and 2004. We 
advocate that community-based 
epidemiological studies should be done in 
order to determine the prevalence of HIV 
seropositivity in the general pediatric 
population. Implementation of standard 
preventive measures especially health 
education/risk control programs and measures 
aimed at preventing mother-to-child 
transmission of HIV is recommended. 
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